What is PAXUS™ PM?
Active pharmaceutical ingredient of PAXUS™ PM, is paclitaxel which belongs to the group of medicines called antineoplastics. This particular paclitaxel product contains no toxic solvents, unlike other conventional paclitaxel products. This may reduce some of the adverse effects such as allergic reactions that may be caused by these solvents other ingredients.
For Whom PAXUS™ PM is?
Currently PAXUS™ PM has been used as First-line treatment for Metastatic Breast Cancer (monotherapy), the first-line treatment for locally advanced, metastatic, recurrent Non-Small Cell Lung Cancer (NSCLC), and First-line treatment for Ovarian Cancer in combination with other chemotherapeutic agents.
What are the main benefits of PAXUS™ PM compared to conventional paclitaxel ?
- Cremophor EL-free solubilizer, no severe hypersensitivity reaction
- High dose, improved therapeutic effect with predictable safety profile
- Hassle-free drug delivery, no special infusion set is required